Skip to the page

Data / Drug companies / Eskayef Pharmaceuticals Limited

Eskayef Pharmaceuticals Limited: 13 products in the FDA NDC directory, labeler code 72658

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Eskayef Pharmaceuticals Limited (labeler code 72658) lists 13 products in the FDA National Drug Code Directory, covering 3 finished drugs by generic name. By type: 13 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 10, 2026.

The request: Watch Eskayef Pharmaceuticals Limited (FDA labeler code 72658): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72658
Products in commercial distribution
13
Packages
45
Finished drugs by generic name
3
Prescription products
13
Over the counter products
0
Controlled substance products
Schedule V 8
Flagged as original packager
13 of 13 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
April 4, 2022
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)13100%

Products by type

TypeProductsShare
Prescription drugs13100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Pregabalin854
Paliperidone419
Calcium chloride114

Dosage forms

Dosage formProductsShare
Capsule861.5%
Tablet, extended release430.8%
Injection, solution17.7%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Calcium chloride72658-1879Injection, solutionGeneric drugs (ANDA)September 10, 2026
Paliperidone72658-1256Tablet, extended releaseGeneric drugs (ANDA)October 2, 2025
Paliperidone72658-1255Tablet, extended releaseGeneric drugs (ANDA)October 2, 2025
Paliperidone72658-1254Tablet, extended releaseGeneric drugs (ANDA)October 2, 2025
Paliperidone72658-1253Tablet, extended releaseGeneric drugs (ANDA)October 2, 2025
Pregabalin72658-0849CapsuleGeneric drugs (ANDA)April 4, 2022
Pregabalin72658-0814CapsuleGeneric drugs (ANDA)April 4, 2022
Pregabalin72658-0813CapsuleGeneric drugs (ANDA)April 4, 2022
Pregabalin72658-0812CapsuleGeneric drugs (ANDA)April 4, 2022
Pregabalin72658-0811CapsuleGeneric drugs (ANDA)April 4, 2022
Pregabalin72658-0810CapsuleGeneric drugs (ANDA)April 4, 2022
Pregabalin72658-0809CapsuleGeneric drugs (ANDA)April 4, 2022
Pregabalin72658-0808CapsuleGeneric drugs (ANDA)April 4, 2022

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.